Alphatec/$ATEC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Alphatec

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Ticker

$ATEC
Primary listing

Industry

Health Care Equipment & Supplies

Employees

867

ISIN

US02081G2012

Alphatec Metrics

BasicAdvanced
$1.7B
-
-$1.15
1.07
-

What the Analysts think about Alphatec

Analyst ratings (Buy, Hold, Sell) for Alphatec stock.

Bulls say / Bears say

Alphatec Holdings has consistently outperformed sales expectations, successfully capturing market share in the $8 billion U.S. spinal disorder treatment market. (seekingalpha.com)
Analysts maintain a 'Strong Buy' consensus for ATEC, with a 12-month price target of $17.3, indicating a potential upside of approximately 62.88%. (stockanalysis.com)
The company's innovative product suite, including the Alpha InformatiX platform and integration of navigation and robotics in spine procedures, positions it favorably in a growing market. (directorstalkinterviews.com)
Alphatec Holdings reported a negative EPS of -1.14 and free cash flow of -$24,319,624, indicating ongoing profitability challenges. (directorstalkinterviews.com)
The company's debt-to-equity ratio increased to 5.09 as of December 31, 2023, suggesting a higher reliance on debt financing, which could pose financial risks. (siriusinvestors.com)
Alphatec's stock price may fluctuate significantly due to factors such as volume and timing of product orders, competition, and changes in healthcare policy, potentially impacting investor returns. (tipranks.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.

Alphatec Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Alphatec Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ATEC

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs